1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst Leibert arrived unannounced for the purpose of delivering findings on this complaint. During the course of this investigation, statements were taken and documents reviewed. The following determinations are made: Management acknowledges the error made with Resident’s (R1) medication. On 10/14 R1 was given 1 tab of Glipizide but R1’s order calls for 1/2 tab. R1 was also administered insulin which is no longer ordered for R1. In addition, the MAR (Medication Administration Record) incorrectly indicates that R1 was dispensed 1/2 tab of Glipizide when, in fact, R1 was administered 1 tab. Based upon statements and documents, the Preponderance of evidence standard has been met. Therefore, the allegations are SUBSTANTIATED.
The following deficiencies were observed (see LIC 9099D) and cited from the California Code of Regulations, Title 22, Division 6 of California Regulation. Failure to correct the deficiency and/or repeat deficiencies within a 12 month period may result in civil penalties. Exit interview conducted and appeal of rights provided.
|